Australia · Delayed Price · Currency is AUD Clinuvel Pharmaceuticals Statistics
Total Valuation
ASX:CUV has a market cap or net worth of AUD 566.40 million. The enterprise value is 342.82 million.
| Market Cap | 566.40M |
| Enterprise Value | 342.82M |
Important Dates
The next estimated earnings date is Thursday, November 27, 2025.
| Earnings Date | Nov 27, 2025 |
| Ex-Dividend Date | Sep 4, 2025 |
Share Statistics
ASX:CUV has 50.12 million shares outstanding. The number of shares has decreased by -1.27% in one year.
| Current Share Class | 50.12M |
| Shares Outstanding | 50.12M |
| Shares Change (YoY) | -1.27% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 10.28% |
| Owned by Institutions (%) | 23.23% |
| Float | 41.49M |
Valuation Ratios
The trailing PE ratio is 15.74 and the forward PE ratio is 15.26. ASX:CUV's PEG ratio is 2.06.
| PE Ratio | 15.74 |
| Forward PE | 15.26 |
| PS Ratio | 5.96 |
| PB Ratio | 2.35 |
| P/TBV Ratio | 2.35 |
| P/FCF Ratio | 13.88 |
| P/OCF Ratio | 13.78 |
| PEG Ratio | 2.06 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.31, with an EV/FCF ratio of 8.40.
| EV / Earnings | 9.48 |
| EV / Sales | 3.61 |
| EV / EBITDA | 7.31 |
| EV / EBIT | 7.49 |
| EV / FCF | 8.40 |
Financial Position
The company has a current ratio of 9.66, with a Debt / Equity ratio of 0.00.
| Current Ratio | 9.66 |
| Quick Ratio | 9.25 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 10.25 |
Financial Efficiency
Return on equity (ROE) is 16.30% and return on invested capital (ROIC) is 12.85%.
| Return on Equity (ROE) | 16.30% |
| Return on Assets (ROA) | 11.37% |
| Return on Invested Capital (ROIC) | 12.85% |
| Return on Capital Employed (ROCE) | 18.71% |
| Revenue Per Employee | 5.94M |
| Profits Per Employee | 2.26M |
| Employee Count | 16 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 0.87 |
Taxes
In the past 12 months, ASX:CUV has paid 15.38 million in taxes.
| Income Tax | 15.38M |
| Effective Tax Rate | 29.83% |
Stock Price Statistics
The stock price has decreased by -21.09% in the last 52 weeks. The beta is 0.71, so ASX:CUV's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -21.09% |
| 50-Day Moving Average | 11.82 |
| 200-Day Moving Average | 11.32 |
| Relative Strength Index (RSI) | 48.66 |
| Average Volume (20 Days) | 206,936 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:CUV had revenue of AUD 95.02 million and earned 36.17 million in profits. Earnings per share was 0.72.
| Revenue | 95.02M |
| Gross Profit | 86.54M |
| Operating Income | 45.76M |
| Pretax Income | 51.55M |
| Net Income | 36.17M |
| EBITDA | 46.54M |
| EBIT | 45.76M |
| Earnings Per Share (EPS) | 0.72 |
Balance Sheet
The company has 224.11 million in cash and 528,528 in debt, giving a net cash position of 223.58 million or 4.46 per share.
| Cash & Cash Equivalents | 224.11M |
| Total Debt | 528,528 |
| Net Cash | 223.58M |
| Net Cash Per Share | 4.46 |
| Equity (Book Value) | 240.81M |
| Book Value Per Share | 4.80 |
| Working Capital | 235.76M |
Cash Flow
In the last 12 months, operating cash flow was 41.10 million and capital expenditures -298,567, giving a free cash flow of 40.80 million.
| Operating Cash Flow | 41.10M |
| Capital Expenditures | -298,567 |
| Free Cash Flow | 40.80M |
| FCF Per Share | 0.81 |
Margins
Gross margin is 91.08%, with operating and profit margins of 48.16% and 38.07%.
| Gross Margin | 91.08% |
| Operating Margin | 48.16% |
| Pretax Margin | 54.26% |
| Profit Margin | 38.07% |
| EBITDA Margin | 48.98% |
| EBIT Margin | 48.16% |
| FCF Margin | 42.94% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.44%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.44% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.92% |
| Buyback Yield | 1.27% |
| Shareholder Yield | 1.71% |
| Earnings Yield | 6.39% |
| FCF Yield | 7.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 12, 2010. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 12, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
ASX:CUV has an Altman Z-Score of 14.53 and a Piotroski F-Score of 5.
| Altman Z-Score | 14.53 |
| Piotroski F-Score | 5 |